Home
News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF
The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring
About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info
Where is LF?
Countries and Map List
Country Summary Data
Moving Forward
Starting Out
Success Stories
Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
   Burkina Faso
   Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

Economics of LF

LF is a leading cause of permanent disability and one of the neglected diseases that, if targeted, will provide much needed health care to the poorest of the poor, thus increasing their health, quality of life, and potential productivity. Eliminating LF is one step closer to creating vibrant productive communities for future generations.

Socio-economic research on lymphatic filariasis covers a broad range of topics concentrated on:

  • Quantifying productivity loss due to LF
  • Measuring the financial burden of treatment for individuals and health care systems
  • Calculating the cost of the elimination programme and identifying affordable strategies
  • Cost-effectiveness of LF elimination programmes

80% of LF endemic countries are low or lower-middle income countries.

Almost $1 billion dollars are lost in India every year due to decreased productivity from LF.

In some LF endemic health districts, 15-25% of all surgeries are for hydrocele.

Mass drug administration treatment is extremely cost effective - typically about a dollar per person per year, and often less.

Governments and in-country sources contribute substantially to national LF elimination programmes, including 72% in Egypt.

Socio-economic research allows for the allocation of limited resources for the greatest impact. Results are used by government policymakers, programme managers, and LF advocates in endemic countries, as well as private, bilateral and multilateral donors. Socio-economic research provides information about efficiency in achieving results and programme sustainability. It can be used to project future programme needs and stimulate the development of new and better ways of carrying out activities.

An Affordable Elimination Programme
A feasible, effective, and inexpensive prevention strategy is already in place with the administration of two oral drugs once a year. Mass drug administration (MDA) campaigns distribute albendazole plus diethylcarbamazine (DEC) or Mectizan® (ivermectin) to the general population in endemic areas. Annual administration of the drugs, for at least five years, is adequate to interrupt transmission of the parasite that causes LF. Costs for MDAs vary among countries but are typically much lower than $1.00 per person treated. An alternative strategy is to fortify salt with DEC. Two years of DEC-fortified salt consumption in over 80% of the endemic population will break the transmission cycle.

Lymphatic Filariasis Decreases Productivity and Income
LF is estimated to cause several billion US dollars a year in productivity losses. Chronic LF patients in Orissa, India lost a total of 68 days of work per year, equivalent to 19% of the total working time of the year. In fact, in all of India, lost productivity due to LF is estimated at almost US$1billion a year. Entire communities have changed productive pursuits to adapt to LF. These activities often have lower economic returns but are less physically demanding.

Financial Burden on Patients and Health Care Systems in addition to the lost productivity and costs for medical treatment add an extra burden. For example, three-quarters of chronic LF patients in rural communities in Orissa, India sought treatment for their conditions. They spent an average of US$8.70 a year on treatment, mostly on medicines, equivalent to 2% of the average yearly wage.

LF creates a major drain on government resources through medical care and treatment provided by government hospitals and clinics. It is common to seek treatment for acute attacks and hydrocele surgery creates additional costs. In a hospital in Northern Ghana, 25% of all surgeries in 1998 were for hydrocele.

Integration of LF Elimination with Public Health Programmes to Reduce Costs
LF strategies can be integrated into other programmes to improve cost effectiveness. Mass drug administration can be combined with programmes to eliminate onchocerciasis and trachoma, to fight Vitamin A deficiency, and with immunization programmes. DEC-salt fortification to eliminate LF transmission can be combined with iodine and micronutrient fortification schemes. In addition, development projects that reduce mosquito breeding sites, improve housing and sanitation facilities and stimulate economic development are likely to aid in reducing the transmission of LF. Beyond integrating LF treatment with other diseases, the drugs that prevent LF also eliminate intestinal worms, providing an additional, immediate benefit. Annual treatment in Haiti and elsewhere has shown dramatic and persistent reductions in hookworm and roundworm infections, improving children’s growth and nutrition.

Additional Socio-Economic Information
Information on socio-economic consequences of the disease and the benefits of national programmes to eliminate it is still forthcoming. More studies are needed globally to better document the costs of LF-related disability and the costs of different strategies to combat LF. Click here to link to www.filariasis.us for more information about ongoing socio-economic projects.

Following are selected resources pertaining to the economics of lymphatic filariasis:

Socio-Economic Impact of LF and the Programme to Eliminate It: A short document referencing the social and economic consequences of lymphatic filariasis and the impact of the programme to eliminate the disease. Available in English and French.

Bibliography of Selected Socio-Economic Studies of LF: Abstracts from over 30 studies examining the impact of LF worldwide.

LF: Economic Aspects of the Disease and Programmes for its Elimination: This article examines the economic evidence linking LF with poverty.

The Elimination of LF: A Strategy for Poverty Alleviation and Sustainable Development : Written by Jaime Galvez Tan, former Chair of the Global Alliance, this article discusses the impact of LF and the programme to eliminate it in the Philippines.


 

 

© Global Alliance to Eliminate Lymphatic Filariasis